| Page 134 | Kisaco Research

Russel Bagnall, Partner, Adams & Adams

The quality of the presentations was very high, and the content was very relevant. The conference was a good size-large enough to have meaningful network opportunities but still small enough to provide an intimate feel.

Maria Balestriero, IP Lawyer, Portolano Cavallo

Two inspiring days! Once again attending this conference proved to be to be a unique opportunity not only to see colleagues and friends from all over the world and for new connections, but also to catch up and discuss with them the latest developments in current topics in pharma and biotech patent litigation.

Michael Lee, Senior Director of Patents, Norgine

Brilliantly organised event, great mix of practice and industry attendees, a highly relevant and useful series of panel talks, and a good balance of networking and content.

Victoria Flowers, Executive Director Forensics, Mazars

The Pharma/Biotech Patent Litigation Europe Conference was very informative and offered many opportunities for networking with relevant contacts.

Christoph Rehfuess, Head of IP, Sotio

This was a thrilling event bringing together IP experts from originators, generics/biosimiars and judges into exciting panel discussions on the most immanent topics in Pharma/Biotech patent litigation.

Kit Carter, Global Head of IP Litigation, Sandoz

This has rapidly become the must go to event for pharma patent litigation. Not to be missed.

Georgia Roussou, Senior Legal Counsel, Win Medica

I believe it is the most interesting and useful conference for both lawyers and patent attorneys in the pharmaceutical industry.

Filipe Pedro, Director of IP, BIAL

The topics were very interesting and pertinent, so it was an excellent opportunity to see what is happening in several different areas of IP. It was also great for the quality of the speakers and excellent to meet people from other companies and law firms.